Results 31 to 40 of about 531,871 (379)

A Universally Primed-Polymerase Chain Reaction (UP-PCR) Marker to Discriminate Clonostachys rosea ACM941 from Related Strains

open access: yesJournal of Fungi, 2019
Clonostachys rosea strain ACM941 is an effective biocontrol agent against several crop diseases including Fusarium head blight. In anticipation of its increased relevance going forward, the development of a reliable DNA-based molecular marker to track it
Zerihun A. Demissie   +2 more
doaj   +1 more source

Adjuvant Chemotherapy [PDF]

open access: yesSurgical Clinics of North America, 1986
At present, adjuvant chemotherapy exerts no significant impact on long-term survival and only occasionally provides brief palliation in head and neck cancer. The major contribution of chemotherapy has been in the preoperative period, when therapy for advanced squamous cell carcinoma may render some patients candidates for curative operations or ...
C K, Osborne, C A, Coltman
openaire   +4 more sources

Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection [PDF]

open access: yes, 2014
Background/Purpose: A proper adjuvant has a relevant role in vaccine formulations to generate an effective immune response. In this study, total Leishmania antigen (TLA) formulated with Montanide ISA 763 or R848 as adjuvants were evaluated as a first ...
Cargnelutti, Diego Esteban   +6 more
core   +1 more source

“World in motion” – emulsion adjuvants rising to meet the pandemic challenges

open access: yesnpj Vaccines, 2021
Emulsion adjuvants such as MF59 and AS03 have been used for more than two decades as key components of licensed vaccines, with over 100 million doses administered to diverse populations in more than 30 countries.
D. O’hagan   +4 more
semanticscholar   +1 more source

Influence of surfactant‐humectant adjuvants on physical properties, droplet size, and efficacy of glufosinate formulations

open access: yesAgrosystems, Geosciences & Environment, 2022
Glufosinate efficacy is inconsistent among weed species and under environmental conditions that favor rapid droplet drying. Surfactant‐humectant adjuvants could maximize glufosinate efficacy by increasing wetting and penetration into the leaf surface ...
Estefania G. Polli   +3 more
doaj   +1 more source

Adjuvant treatment [PDF]

open access: yesHPB, 2006
Exocrine pancreatic cancer (pancreatic ductal adenocarcinoma) is one of the leading causes of cancer deaths in the western world, accounting for 5% of all cancer-related deaths. Only a small percentage of patients with pancreatic cancer are able to undergo potentially curative resection, even in specialized centres, and prognosis remains poor after ...
Sultana, Asma   +2 more
openaire   +2 more sources

Vaccines against toxoplasma gondii : challenges and opportunities [PDF]

open access: yes, 2009
Development of vaccines against Toxoplasma gondii infection in humans is of high priority, given the high burden of disease in some areas of the world like South America, and the lack of effective drugs with few adverse effects.
Aliberti J   +117 more
core   +3 more sources

A comparison of cancer vaccine adjuvants in clinical trials

open access: yesCancer Treatment and Research Communications, 2023
Cancer treatment has come a long way in increasing overall survival; however, evasion of the immune system continues to be a challenge in treating individuals with established disease burdens.
Morgan Marriott   +2 more
doaj   +1 more source

Effects of Adjuvants on Spraying Characteristics and Control Efficacy in Unmanned Aerial Application

open access: yesAgriculture, 2022
Pesticide application by unmanned agricultural aerial vehicles (UAVs) has rapidly developed in China and other Asian counties. Currently, tank-mix spray adjuvants are usually added into pesticide solutions to reduce spray drift and facilitate droplet ...
Shilin Wang   +6 more
doaj   +1 more source

Immunogens and Antigen Processing: Report from a Global HIV Vaccine Enterprise Working Group [PDF]

open access: yes, 2010
The Global HIV Vaccine Enterprise convened a meeting of a Working Group in July 2009 to discuss recent progress in rational design of the components of an HIV vaccine, such as inserts, vectors and adjuvants,and in understanding antigen processing and ...
John Mascola   +3 more
core   +3 more sources

Home - About - Disclaimer - Privacy